Publication | Closed Access

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Equine-assisted TherapyAnimal HealthBone Marrow FailureAnimal ScienceHematologyImmunologyPathologyVeterinary SciencePhase Ii StudyAutoimmunityLow-risk Myelodysplastic SyndromesEducationVeterinary ResearchTherapeutic EfficacyImmune-modulating TherapyImmunotherapyMedicine